Clinical study of the psychostimulant action of amantadine
Castaigne, P.; Laplane, D.; Autret, A.
La Nouvelle Presse Medicale 3(26): 1663-1664
1974
ISSN/ISBN: 0301-1518 PMID: 4602601 Document Number: 81175
Document emailed within 1 workday
Related Documents
Krapivin, S.V.; Morozov, I.S. 1994: A neurophysiological analysis of the action of psychostimulant agents Eksperimental'naia i Klinicheskaia Farmakologiia 57(5): 66-72Arushanian, E.B. 1975: Neurochemical and neurophysiological mechanisms of the psychostimulant action of phenamine Farmakologiia i Toksikologiia 38(1): 111-120
Merrick, E.M.; Schmitt, P.P. 1973: A controlled study of the clinical effects of amantadine hydrochloride (Symmetrel) Current Therapeutic Research 15(8): 552-558
Pennacchietti, M.; Aletto, P.M. 1971: On the action of amantadine in postencephalitic parkinsonism Minerva Medica 62(82): 3960-3962
Agnoli, A.; Casacchia, M.; Ruggieri, S.; Volante, F.; Accornero, N. 1971: Action of amantadine on parkinsonian tremor Minerva Medica 62(82): 3990-3993
Danielczyk, W.; Korten, J.J. 1971: Action of amantadine HCl alone and in combination with L-dopa on parkinsonism Medizinische Monatsschrift 25(10): 472-479
Tsai, M.C.; Mansour, N.A.; Eldefrawi, A.T.; Eldefrawi, M.E.; Albuquerque, E.X. 1978: Mechanism of action of amantadine on neuromuscular transmission Molecular Pharmacology 14(5): 787-803
Mitolo-Chieppa, D. 1973: Action of an antiviral drug, amantadine, on isolated nerve fibers Bollettino della Societa Italiana di Biologia Sperimentale 49(17): 965-971
Saran, B.M.; Klein, M.S.; Benay, E.M. 1980: Clinical evaluation of amantadine and haloperidol in Huntington's chorea Journal of Clinical Psychiatry 41(6): 221
Ambrosetto, C.; Martinelli, P. 1971: Clinical considerations on therapy of parkinsonian syndromes with amantadine and L-Dopa Minerva Medica 62(82): 4017-4019
Bukowczyk, A.; Wasik, A.; Horodnicki, J. 1974: Clinical evaluation of amantadine in the treatment of extrapyramidal syndromes caused by neuroleptic drugs Psychiatria Polska 8(2): 143-148
Dzudza, M.; Dzudza, D. 1974: Comparative study on Parkopan, Amantadine and L-dopa in the treatment of Parkinson's disease Medicinski Arhiv 28(4): 407-415
Silver, D.E.; Sahs, A.L. 1971: Double blind study using amantadine hydrochloride in the therapy of Parkinson's disease Transactions of the American Neurological Association 96: 307-308
Xu, H.; Qian, Y.; Xu, H.; Zhang, J.-h.; Zhu, R.-n.; Wang, F. 2006: Resistance to amantadine of epidemic strain of H3 subtype influenza virus: a primary study Zhonghua Yi Xue Za Zhi 86(14): 996-998
Kulichenko, L.L.; Kireyeva, L.V.; Malyshkina, E.N.; Wikman, G. 2003: A randomized, controlled study of Kan Jang versus amantadine in the treatment of influenza in Volgograd Journal of Herbal PharmacoTherapy 3(1): 77-93
Cheliapina, M.V.; Sharova, E.V.; Zaĭtsev, O.S. 2011: Clinical and electroencephalographic effects of amantadine sulfate (PK-Merz) on consciousness disorders due to the severe traumatic brain injury Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 111(5): 24-29
Abe, H. 1978: Clinical study on the mode of action of various diuretics Nihon Jinzo Gakkai Shi 20(8): 853-876
Garagnani Sciarretta, B.; Rimondini, S.; Martelli, A. 1974: On the encephalotrophic action of hydergine. Clinical study Minerva Medica 65(59): 3090-3098
Rech, R.H. 1978: Brain lesions and psychostimulant drugs Psychopharmacology Bulletin 14(4): 35-38
Lingjaerde, O. 1972: Psychostimulant treatment of "hyperkinetic" children Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 92(1): 34-35